Correlation Between Iovance Biotherapeutics and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Sana Biotechnology, you can compare the effects of market volatilities on Iovance Biotherapeutics and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Sana Biotechnology.
Diversification Opportunities for Iovance Biotherapeutics and Sana Biotechnology
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Iovance and Sana is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Sana Biotechnology go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Sana Biotechnology
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Sana Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Iovance Biotherapeutics is 5.06 times less risky than Sana Biotechnology. The stock trades about -0.24 of its potential returns per unit of risk. The Sana Biotechnology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 161.00 in Sana Biotechnology on December 27, 2024 and sell it today you would earn a total of 24.00 from holding Sana Biotechnology or generate 14.91% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Iovance Biotherapeutics vs. Sana Biotechnology
Performance |
Timeline |
Iovance Biotherapeutics |
Sana Biotechnology |
Iovance Biotherapeutics and Sana Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iovance Biotherapeutics and Sana Biotechnology
The main advantage of trading using opposite Iovance Biotherapeutics and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements |